BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28637725)

  • 1. Filling the gaps in SARDs research: collection and linkage of administrative health data and self-reported survey data for a general population-based cohort of individuals with and without diagnoses of systemic autoimmune rheumatic disease (SARDs) from British Columbia, Canada.
    McCormick N; Reimer K; Famouri A; Marra CA; Aviña-Zubieta JA
    BMJ Open; 2017 Jun; 7(6):e013977. PubMed ID: 28637725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excess Productivity Costs of Systemic Lupus Erythematosus, Systemic Sclerosis, and Sjögren's Syndrome: A General Population-Based Study.
    McCormick N; Marra CA; Sadatsafavi M; Kopec JA; Aviña-Zubieta JA
    Arthritis Care Res (Hoboken); 2019 Jan; 71(1):142-154. PubMed ID: 29648677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic autoimmune rheumatic diseases and multiple industrial air pollutant emissions: A large general population Canadian cohort analysis.
    Zhao N; Smargiassi A; Chen H; Widdifield J; Bernatsky S
    Environ Int; 2023 Apr; 174():107920. PubMed ID: 37068387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
    Yang Z; Ren Y; Liu D; Lin F; Liang Y
    APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression and COVID-19 infection in British Columbia: Protocol for a linkage study of population-based administrative and self-reported survey data.
    Avina-Galindo AM; Fazal ZA; Marozoff S; Kwan J; Lu N; Hoens AM; Kopec J; Lacaille D; Xie H; Loree JM; Avina-Zubieta JA;
    PLoS One; 2021; 16(11):e0259601. PubMed ID: 34797824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods study.
    Sloan M; Wincup C; Harwood R; Pollak TA; Massou E; Bosley M; Pitkanen M; Zandi MS; Leschziner G; Barrere C; Ubhi M; Andreoli L; Brimicombe J; Diment W; Jayne D; Gordon C; Naughton F; D'Cruz D
    Rheumatology (Oxford); 2024 May; 63(5):1259-1272. PubMed ID: 37491699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of systemic autoimmune rheumatic diseases using administrative data.
    Bernatsky S; Lix L; Hanly JG; Hudson M; Badley E; Peschken C; Pineau CA; Clarke AE; Fortin PR; Smith M; Bélisle P; Lagace C; Bergeron L; Joseph L
    Rheumatol Int; 2011 Apr; 31(4):549-54. PubMed ID: 20665025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic autoimmune rheumatic disease prevalence in Canada: updated analyses across 7 provinces.
    Broten L; Aviña-Zubieta JA; Lacaille D; Joseph L; Hanly JG; Lix L; O'Donnell S; Barnabe C; Fortin PR; Hudson M; Jean S; Peschken C; Edworthy SM; Svenson L; Pineau CA; Clarke AE; Smith M; Bélisle P; Badley EM; Bergeron L; Bernatsky S
    J Rheumatol; 2014 Apr; 41(4):673-9. PubMed ID: 24584928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine particulate air pollution and systemic autoimmune rheumatic disease in two Canadian provinces.
    Bernatsky S; Smargiassi A; Barnabe C; Svenson LW; Brand A; Martin RV; Hudson M; Clarke AE; Fortin PR; van Donkelaar A; Edworthy S; Bélisle P; Joseph L
    Environ Res; 2016 Apr; 146():85-91. PubMed ID: 26724462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Productivity Losses and Costs in the Less-Common Systemic Autoimmune Rheumatic Diseases.
    McCormick N; Marra CA; Aviña-Zubieta JA
    Curr Rheumatol Rep; 2017 Oct; 19(11):72. PubMed ID: 29086172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of systemic autoimmune rheumatic diseases in Canadian pediatric populations: administrative database estimates.
    Shiff NJ; Lix LM; Joseph L; Duffy C; Tucker LB; Svenson LW; Belisle P; Bernatsky S
    Rheumatol Int; 2015 Mar; 35(3):569-73. PubMed ID: 25257764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of health-related quality of life (HRQoL) across four systemic autoimmune rheumatic diseases (SARDs).
    Greenfield J; Hudson M; Vinet E; Fortin PR; Bykerk V; Pineau CA; Wang M; Bernatsky S; Baron M;
    PLoS One; 2017; 12(12):e0189840. PubMed ID: 29261752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case-control study.
    Gadalla SM; Amr S; Langenberg P; Baumgarten M; Davidson WF; Schairer C; Engels EA; Pfeiffer RM; Goedert JJ
    Br J Cancer; 2009 Mar; 100(5):817-21. PubMed ID: 19190628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airborne pollutants as potential triggers of systemic autoimmune rheumatic diseases: a narrative review.
    Celen H; Dens AC; Ronsmans S; Michiels S; De Langhe E
    Acta Clin Belg; 2022 Oct; 77(5):874-882. PubMed ID: 34666637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Risk in Patients With Inflammatory Systemic Autoimmune Rheumatic Diseases: A Nationwide Population-Based Dynamic Cohort Study in Taiwan.
    Yu KH; Kuo CF; Huang LH; Huang WK; See LC
    Medicine (Baltimore); 2016 May; 95(18):e3540. PubMed ID: 27149461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine particulate air pollution, nitrogen dioxide, and systemic autoimmune rheumatic disease in Calgary, Alberta.
    Bernatsky S; Smargiassi A; Johnson M; Kaplan GG; Barnabe C; Svenson L; Brand A; Bertazzon S; Hudson M; Clarke AE; Fortin PR; Edworthy S; Bélisle P; Joseph L
    Environ Res; 2015 Jul; 140():474-8. PubMed ID: 25988990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of interstitial lung disease in patients with newly diagnosed systemic autoimmune rheumatic disease: A nationwide, population-based cohort study.
    Ng KH; Chen DY; Lin CH; Chao WC; Chen YM; Chen YH; Huang WN; Hsieh TY; Lai KL; Tang KT; Chen HH
    Semin Arthritis Rheum; 2020 Oct; 50(5):840-845. PubMed ID: 32896697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of neutrophil-, monocyte-, eosinophil-, and basophil- lymphocyte ratios among various systemic autoimmune rheumatic diseases.
    Yang Z; Zhang Z; Lin F; Ren Y; Liu D; Zhong R; Liang Y
    APMIS; 2017 Oct; 125(10):863-871. PubMed ID: 28766758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and outcomes for repeat COVID-19 infection among patients with systemic autoimmune rheumatic diseases: A case-control study.
    Kowalski EN; Wang X; Patel NJ; Kawano Y; Cook CE; Vanni KMM; Qian G; Bade KJ; Srivatsan S; Williams ZK; Wallace ZS; Sparks JA
    Semin Arthritis Rheum; 2023 Dec; 63():152286. PubMed ID: 37913612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cohort study: The Association Between Autoimmune Disorders and Leptospirosis.
    Teh SH; You RI; Yang YC; Hsu CY; Pang CY
    Sci Rep; 2020 Feb; 10(1):3276. PubMed ID: 32094396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.